Paper17518571
In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study.
Lareu RR and 4 others. Tissue Eng, 2007. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study. Papers, record 17518571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17518571
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Culture Techniques | Major topic |
| Collagen | Major topic |
| Dextran Sulfate | Major topic |
| Extracellular Matrix | Major topic |
| Fibroblasts | Major topic |
| Tissue Engineering | Major topic |
| Cell Line | |
| Cell Proliferation | |
| Cell Survival | |
| Cross-Linking Reagents | |
| Humans | |
| Pilot Projects |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40331149 | Underestimated role of macromolecular crowding in bioengineered in vitro models of health and diseases. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40331149 | PubMed |
| 39435160 | Profiling of collagen and extracellular matrix deposition from cell culture using in vitro ExtraCellular matrix mass spectrometry imaging (ivECM-MSI). | Matrix Biol Plus | 2024 | https://conductscience.org/library/papers/39435160 | PubMed |
| 39214607 | Harnessing the Biomimetic Effect of Macromolecular Crowding in the Cell-Derived Model of Clubfoot Fibrosis. | Biomacromolecules | 2024 | https://conductscience.org/library/papers/39214607 | PubMed |
| 38987293 | Human amniotic membrane modulates collagen production and deposition in vitro. | Sci Rep | 2024 | https://conductscience.org/library/papers/38987293 | PubMed |
| 38672707 | Gums as Macromolecular Crowding Agents in Human Skin Fibroblast Cultures. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672707 | PubMed |
| 38650027 | Carrageenan maintains the contractile phenotype of vascular smooth muscle cells by increasing macromolecular crowding in vitro. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38650027 | PubMed |
| 38511512 | Factors Affecting the Evaluation of Collagen Deposition and Fibrosis In Vitro. | Tissue Eng Part A | 2024 | https://conductscience.org/library/papers/38511512 | PubMed |
| 38139263 | Optimization of Sirius Red-Based Microplate Assay to Investigate Collagen Production In Vitro. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139263 | PubMed |
| 37754385 | Carrageenan-Based Crowding and Confinement Combination Approach to Increase Collagen Deposition for In Vitro Tissue Development. | Gels | 2023 | https://conductscience.org/library/papers/37754385 | PubMed |
| 35846945 | Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35846945 | PubMed |
| 35159087 | Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159087 | PubMed |
| 34389806 | Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer. | Br J Cancer | 2021 | https://conductscience.org/library/papers/34389806 | PubMed |
| 34028738 | Techniques to Assess Collagen Synthesis, Deposition, and Cross-Linking In Vitro. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34028738 | PubMed |
| 33782415 | Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast. | NPJ Regen Med | 2021 | https://conductscience.org/library/papers/33782415 | PubMed |
| 33521022 | Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited. | Front Med (Lausanne) | 2020 | https://conductscience.org/library/papers/33521022 | PubMed |
| 33467715 | Lithium Reduces Migration and Collagen Synthesis Activity in Human Cardiac Fibroblasts by Inhibiting Store-Operated Ca2+ Entry. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33467715 | PubMed |
| 33057073 | Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis. | Sci Rep | 2020 | https://conductscience.org/library/papers/33057073 | PubMed |
| 32596531 | Of balls, inks and cages: Hybrid biofabrication of 3D tissue analogs. | Int J Bioprint | 2019 | https://conductscience.org/library/papers/32596531 | PubMed |
| 32381012 | Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis. | Respir Res | 2020 | https://conductscience.org/library/papers/32381012 | PubMed |
| 31453262 | Primary cell-based phenotypic assays to pharmacologically and genetically study fibrotic diseases in vitro. | J Biol Methods | 2019 | https://conductscience.org/library/papers/31453262 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17518571
GET https://conductscience.org/api/papers/v1/17518571/cited_by?page=2